Chloroquine Autophagy/Lysosome inhibitor

Cat.No.S6999

Chloroquine is an antimalarial drug and autophagy/lysosome inhibitor. Chloroquine also suppresses Toll-like receptor-9 (TLR9) protein expression. Chloroquine is highly effective agianst SARS-CoV-2 (COVID-19) infection with EC50 of 1.13 μM in Vero E6 cells. Chloroquine has anti-HIV-1 activity.
Chloroquine Autophagy inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 319.87

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 319.87 Formula

C18H26ClN3

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 54-05-7 -- Storage of Stock Solutions

Synonyms NSC-187208, CHQ, CQ Smiles CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl

Solubility

In vitro
Batch:

DMSO : 64 mg/mL (200.08 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 64 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
Autophagy [1]
lysosome [1]
TLR9 [2]
HIV-1 [4]
SARS-CoV-2 [3]
(Vero E6 cells based assay)
1.13 μM(EC50)
In vitro

Chloroquine is a widely used autophagy inhibitor.[5]

In vivo

The inhibition of autophagy by chloroquine potentiates the therapeutic effect of PI3K/AKT inhibitors in vitro and in vivo TNBC models, synergizing with taxane-based chemotherapy.[6]

References
  • [4] https://pubmed.ncbi.nlm.nih.gov/11166661/
  • [5] https://pubmed.ncbi.nlm.nih.gov/33638615/
  • [6] https://pubmed.ncbi.nlm.nih.gov/35761360/

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05972551 Recruiting
Osteogenesis Imperfecta
Amgen
April 22 2024 Phase 3
NCT05890573 Recruiting
Pulmonary Fibrosis|COVID-19 Pneumonia
Second Affiliated Hospital School of Medicine Zhejiang University
April 16 2024 Not Applicable
NCT05841758 Not yet recruiting
Sarcoidosis Pulmonary
Hospices Civils de Lyon
April 1 2024 Phase 4
NCT03994874 Not yet recruiting
Congestive Heart Failure
Iperboreal Pharma Srl
March 2024 Phase 1|Phase 2
NCT06117722 Not yet recruiting
Chronic Heart Failure
Elpen Pharmaceutical Co. Inc.
March 1 2024 --

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Signaling Pathway Map